Interleukin-1β enhances interleukin-1 receptor antagonist content in human somatotroph adenoma cell cultures

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 7, 1998, Pages 2429-2434

  Sauer, J ^a,b   Renner, U ^a   Hopfner, U ^a   Lange, M ^d   Muller A ^e   Strasburger, C J ^f   Pagotto, U ^a   Arzt, E ^c   Stalla, G K ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e UNIVERSITY OF MUNICH   (Germany)

^f LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA;

ADULT; AGED; ARTICLE; CELL CULTURE; CELL GROWTH; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CYTOKINE RELEASE; FEMALE; GENE EXPRESSION REGULATION; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HORMONE RELEASE; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; MALE; PRIORITY JOURNAL; SOMATIC CELL; SUPERNATANT; TISSUE LEVEL;

ADENOMA; ADULT; AGED; CELLS, CULTURED; FEMALE; HUMANS; INTERLEUKIN-1; MALE; MIDDLE AGED; MONOCYTES; PITUITARY NEOPLASMS; RECEPTORS, INTERLEUKIN-1; TUMOR CELLS, CULTURED;

EID: 0031786727     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.7.2429     Document Type: Article

References (52)

1. Besedovsky HO, del Rey A. 1992 Immune-neuroendocrine circuits: integrative role of cytokines. Front Neuroendocrinol. 13:61-94.
2. Ray D, Melmed S. 1997 Pituitary cytokine and growth factor expression and action. Endocr Rev. 18:206-228.
3. Koenig JI, Snow K, Clark BD, et al. 1990 Intrinsic pituitary interleukin 1-β is induced by bacterial lipopolysaccharide. Endocrinology. 126:3053-3058.
4. Takao T, Culp SG, De Souza EB. 1993 Reciprocal modulation of interleukin-1β (IL-1β) and IL-1 receptors by lypopolysacharide (endotoxin) treatment in the mouse brain-endocrine-immune axis. Endocrinology. 132:1497-1504.
5. Bristulf J, Simoncsits A, Bartfai T. 1991 Characterization of a neuronal interleukin 1 receptor and the corresponding mRNA in the mouse anterior pituitary cell line AtT-20. Neurosci Lett. 128:173-176.
6. Parnet P, Brunke DL, Goujon E, et al. 1993 Molecular identification ot two types of interleukin-1 receptors in the murine pituitary gland. J Neuroendocrinol. 5:213-219.
7. French RA, Zachary JF, Dantzer R, et al. 1996 Dual expression of p80 type I and p68 type II interleukin-1 receptors on anterior pituitary cells synthesizing growth hormone. Endocrinology. 137:4027-4036.
8. Green VL, Atkin SL, Speirs V, et al. 1996 Cytokine expression in human anterior pituitary adenomas. Clin Endocrinol (Oxf). 45:179-185.
9. Jones TH, Daniels M, James RA, et al. 1994 Production of bioactive and immunoreactive interleukin-6 (1L-6) and expression of IL-6 messenger ribonucleic acid by human pituitary adenomas. J Clin Endocrinol Metabol. 78:180-187.
10. Arzt E, Stelzer G, Renner U, Lange M, Müller OA, Stalla GK. 1992 Interleukin-2 and interleukin-2 receptor expression in human corticotrophic adenoma and murine pituitary cell cultures. J Clin Invest. 90:1944-1951.
11. Sauer J, Arzt E, Hopfner U, Gumprecht H, Stalla GK. 1994 Expression of interleukin-1 receptor antagonist in human pituitary adenomas in vitro. J Clin Endocrinol Metab. 79:1857-1863.
12. Lennard AC. 1995 Interleukin 1 receptor antagonist. Crit Rev Immunol. 15:77-105.
13. Haskill S, Martin G, Van Le L, et al. 1991 cDNA cloning of an intracellular form of the human interleukin 1 receptor antagonist associated with epithelium. Proc Natl Acad Sci USA. 88:3681-3685.
14. Muzio M, Polentarutti N, Sironi M, et al. 1995 Cloning and characterization of a new isoform of the interleukin 1 receptor antagonist. J Exp Med. 182:623-628.
15. Arend WP, Smith MF, Janson RW, Joslin FG. 1991 IL-1 receptor antagonist and IL-1β production in human monocytes are regulated differently. J Immunol. 147:1530-1536.
16. Wahl SM. 1993 Transforming growth factor-beta mediates IL-1 dependent induction of IL-1 receptor antagonist. J Immunol. 150:3553-3560.
17. Wong HL, Costa GL, Lotze MT, Wahl SM. 1993 Interleukin (IL) 4 differentially regulates monocyte IL-1 family gene expression and synthesis in vitro and in vivo. J Exp Med. 177:775-781.
18. Chomarat P, Vannier E, Dechanet J, et al. 1995 Balance of IL-1 receptor antagonist/IL-1 beta in rheumatoid synovium and its regulation by IL-4 and IL-10. J Immunol. 154:1432-1439.
19. Ruiz de Souza V, Carreno MP, Kaveri SV, et al. 1995 Selective induction of interleukin-1 receptor antagonist and interleukin-8 in human monocytes by normal polyspecific IgG (intravenous immunoglobulin). Eur J Immunol. 25:1267-1273.
20. Martel-Pelletier J, McCollum R, Pelletier JP. 1993 The synthesis of IL-1 receptor antagonist (IL-1 ra) by synovial fibroblasts is markedly increased by the cytokines TNF-α and IL-1. Biochim Biophys Acta. 1175:302-305.
21. Jaffa GJ, Ven Le L, Valea F, et al. 1992 Expression of interleukin-1α, interleukin-1β, and an interleukin-1 receptor antagonist in human retinal pigment epithelial cells. Exp Eye Res. 55:325-335.
22. Uehara A, Gillis S, Arimura A. 1987 Effects of interleukin-1 on hormone release from normal rat pituitary cells in primary culture. Neuroendocrinology. 45:343-347.
23. Bernton EW, Beach JE, Holaday JW, Smallridge RC, Fein HG. 1987 Release of multiple hormones by a direct action of interleukin-1 on pituitary cells. Science. 238:652-654.
24. Niimi M, Sato M, Wada Y, Tamaki M, Takahara J, Kawanishi K. 1994 Analysis of growth hormone release from rat anterior pituitary cells by reverse hemolytic plaque assay: influence of interleukin-1. Life Sci. 55:1807-1813.
25. Renner U, Newton CJ, Pagotto U, Sauer J, Arzt E, Stalla GK. 1995 Involvement of interleukin-1 and interleukin-1 receptor antagonist in rat pituitary cell growth regulation. Endocrinology. 136:3186-3193.
26. Wada Y, Sato M, Niimi M, Tamaki M, Ishida T, Talahara J. 1995 Inhibitory effects of interleukin-1 on growth hormone secretion in conscious male rats. Endocrinology. 136:3936-3941.
27. Peisen J, McDonell L, Mulroney S, Lumpkin M. 1995 Endotoxin-induced suppression of the somatotropic axis is mediated by interleukin-1β and corticotropin-releasing factor in the juvenile rat. Endocrinology. 136:3378-3390.
28. Curti BD, Urba WJ, Longo DL, et al. 1996 Endocrine effects of IL-1 alpha and beta administered in a phase I trial to patients with advanced cancer. J Immunother. 19:142-148.
29. Bernton EW, Meltzer M, Holaday JW. 1988 Suppression of macrophage activation and T-lymphocyte function in hypeprolactinemic mice. Science. 239:401-404.
30. Edwards C, Ghiasuddin S, Yunger L, et al. 1992 In vivo administration of recombinant growth hormone or gamma interferon activates macrophages: enhanced resistance to experimental Salmonella typhimurium infection is correlated with generation of reactive oxygen intermediates. Infect Immun. 60:2514-2521.
31. Kelley KW, Dantzer R. 1991 Growth hormone and prolactin as natural antagonists of glucocorticoids in immunoregulation. In: Plotnikoff N, Murgo A, Faith R, Wybran J, eds. Stress and immunity. Boca Raton, FL: CRC Press; 433-452.
32. Auernhammer CJ, Strasburger CJ. 1995 Effects of growth hormone and insulin-like growth factor I on the immune system. Eur J Endocrinol. 133:635-645.
33. Clark R. 1997 The somatogenic hormones and insulin-like growth factor-1: stimulators of lymphopoiesis and immune function. Endocr Rev. 18:157-179.
34. Arzt E, Buric R, Stelzer G, et al. 1993 Interleukin involvement in anterior pituitary cell growth regulation: effects of interleukin-2 (IL-2) and IL-6. Endocrinology. 132:459-467.
35. Kunert-Radek J, Radek A, Stepien H. 1994 Interleukin-2 stimulates cell proliferation of the growth hormone producing human pituitary adenoma in vitro. Biomed Lett. 49:259-264.
36. Renner U, Brockmeier S, Strasburger CJ, et al. 1994 Growth hormone (GH)-releasing peptide stimulation of GH release from human somatotroph adenoma cells: interaction with GH-releasing hormone, thyrotropin-releasing hormone, and octreotide. J Clin Endocrinol Metab. 78:1090-1096.
37. Sauer J, Castrén M, Hopfner U, Holsboer F, Stella GK, Arzt E. 1996 Inhibition of lipopolysaccharide-induced monocyte interleukin-1 receptor antagonist synthesis by Cortisol: involvement of the mineralocorticoid receptor. J Clin Endocrinol Metab. 81:73-79.
38. McColl SR, Paquin R, Ménard C, Beaulieu AD. 1992 Human neutrophils produce high levels of the interleukin 1 receptor antagonist in response to granulocyte/macrophage colony-stimulating factor and tumor necrosis factor α. J Exp Med. 176:593-598.
39. Chan LS, Hammerberg C, Kang K, Sabb P, Tavakkol A, Cooper KD. 1992 Human dermal fibroblast interleukin-1 receptor antagonist (IL-1ra) and interleukin-1β (IL-1β) mRNA and protein are co-stimulated by phorbol ester: implication for a homeostatic mechanism. J Invest Dermatol. 3:315-322.
40. Tada M, Diserens A-C, Desbaillets I, Jaufeerally R, Hamou M-F, de Tribolet N. 1994 Production of interleukin-1 receptor antagonist by human glioblastoma cells in vitro and in vivo. J Neuroimmunol. 50:187-194.
41. Strasburger C, Barnard G, Toldo L, et al. 1989 Somatotropin as measured by a two-site time-resolved immunofluorometric assay. Clin Chem. 35:913-917.
42. Wong M-L, Bongiorno PB, Rettori V, McCann SM, Licino J. 1997 Interleukin (IL) 1β, IL-1 receptor antagonist, IL-10) and IL-13 gene expression in the central nervous system and anterior pituitary during systemic inflammation: pathophysiological implications. Proc Natl Acad Sci USA. 94:227-232.
43. Butcher C, Steinkasserer A, Tejura S, Lennard A. 1994 Comparison of two promoters controlling expression of secreted or intracellular IL-1 receptor antagonist. J Immunol. 153:701-711.
44. Jones TH, Kennedy RL, Justice SK, Price A. 1993 Interleukin-1 stimulates the release of interleukin-6 from cultured human pituitary adenoma cells. Acta Endocrinol (Copenh). 128:405-410.
45. Honnegger J, Spagnoli A, D'Urso R, el al. 1991 Interleukin-1β modulates the acute release of growth hormone-releasing hormone and somatostatin from rat hypopthalamus in vitro whereas tumor necrosis factor and interleukin-6 have no effect. Endocrinology. 129:1275-1282.
46. Scarborough D, Lee S, Dinarello C, Reichlin S. 1989 Interleukin-1 stimulates somatostatin biosynthesis in primary cultures of fetal rat brain. Endocrinology. 124:549-551.
47. Coleman ES, Elsasser TH, Kemppainen RJ, Coleman DA, Sartin JL. 1993 Effect of endotoxin on pituitary hormone secretion in sheep. Neuroendocrinology. 58:111-122.
48. Watson JM, Lofquist AK, Rinehart CA, et al. 1995 The intracellular IL-1 receptor antagonist alters IL-1-inducible gene expression without blocking exogenous signaling by IL-1β. J Immunol. 155:4467-4475.
49. McKean DJ, Huntoon C, Bell M. 1994 Ligand-induced desensitization of interleukin-1 receptor initiated intracellular signaling events in T helper lymphocytes. J Exp Med. 180:1321-1328.
50. Matta SG, Linner KM, Sharp BM. 1993 Interleukin-1α and interleukin-1β stimulate adrenocorticotropin secretion in the rat through a similar hypothalamic receptor(s): effects of interleukin-1 receptor antagonist protein. Neuroendocrinology. 57:14-22.
51. Oelmann E, Kraemer A, Serve H, et al. 1997 Autocrine interleukin-1 receptor antagonist can support malignant growth of glioblastoma by blocking growth-inhibiting autocrine loop of interleukin-1. Int J Cancer. 71:1066-1076.
52. Chirivi RG, Garofalo A, Padura IM, Mantovani A, Giavazzi R. 1993 Interleukin 1 receptor antagonist inhibits the augmentation of metastasis induced by interleukin 1 or lipopolysaccharide in a human melanoma/nude mouse system. Cancer Res. 53:5051-5054.